<p>BMD = bone mineral density; Prep = prepubertal (age of rats: 6 weeks, duration of exposure: 2 weeks; n = 10 each group); Pub = pubertal (age of rats: 8 weeks, duration of exposure: 4 weeks; n = 8 each group); Postpub = postpubertal (age of rats: 14 weeks, duration of exposure: 10 weeks; n = 8 each group); Data represents mean ± 95% CI. Statistical analysis at defined time points: * p<0.05 versus age-related controls; ** p<0.01 versus age-related controls; *** p<0.001 versus age-related controls.</p
In the past, bone loss in the ovariectomized (OVX) osteoporotic rat model has been monitored using i...
In the past, bone loss in the ovariectomized (OVX) osteoporotic rat model has been monitored using i...
<p>(A–C) pQCT analyses of femurs from wild-type (wt) and tg2 mice at 10 weeks of age. A, pQCT images...
<p>Three dimensional trabecular microarchitecture of the right femora was assessed by μCT. Trabecula...
<div><p>The tyrosine kinase (TK) inhibitor imatinib provides a highly effective therapy for chronic ...
The tyrosine kinase (TK) inhibitor imatinib provides a highly effective therapy for chronic myeloid ...
The tyrosine kinase (TK) inhibitor imatinib provides a highly effective therapy for chronic myeloid ...
Imatinib is a rationally-designed tyrosine kinase inhibitor that is a highly-successful treatment fo...
Imatinib inhibits tyrosine kinases impor-tant in osteoclast (c-Fms) and osteoblast (platelet-derived...
Copyright © 2007 by American Society of HematologyImatinib inhibits tyrosine kinases important in os...
In the past, bone loss in the ovariectomized (OVX) osteoporotic rat model has been monitored using i...
In the past, bone loss in the ovariectomized (OVX) osteoporotic rat model has been monitored using i...
CONTEXT: Imatinib is a tyrosine kinase inhibitor that has been successfully used to treat Philadelph...
In the past, bone loss in the ovariectomized (OVX) osteoporotic rat model has been monitored using i...
In the past, bone loss in the ovariectomized (OVX) osteoporotic rat model has been monitored using i...
In the past, bone loss in the ovariectomized (OVX) osteoporotic rat model has been monitored using i...
In the past, bone loss in the ovariectomized (OVX) osteoporotic rat model has been monitored using i...
<p>(A–C) pQCT analyses of femurs from wild-type (wt) and tg2 mice at 10 weeks of age. A, pQCT images...
<p>Three dimensional trabecular microarchitecture of the right femora was assessed by μCT. Trabecula...
<div><p>The tyrosine kinase (TK) inhibitor imatinib provides a highly effective therapy for chronic ...
The tyrosine kinase (TK) inhibitor imatinib provides a highly effective therapy for chronic myeloid ...
The tyrosine kinase (TK) inhibitor imatinib provides a highly effective therapy for chronic myeloid ...
Imatinib is a rationally-designed tyrosine kinase inhibitor that is a highly-successful treatment fo...
Imatinib inhibits tyrosine kinases impor-tant in osteoclast (c-Fms) and osteoblast (platelet-derived...
Copyright © 2007 by American Society of HematologyImatinib inhibits tyrosine kinases important in os...
In the past, bone loss in the ovariectomized (OVX) osteoporotic rat model has been monitored using i...
In the past, bone loss in the ovariectomized (OVX) osteoporotic rat model has been monitored using i...
CONTEXT: Imatinib is a tyrosine kinase inhibitor that has been successfully used to treat Philadelph...
In the past, bone loss in the ovariectomized (OVX) osteoporotic rat model has been monitored using i...
In the past, bone loss in the ovariectomized (OVX) osteoporotic rat model has been monitored using i...
In the past, bone loss in the ovariectomized (OVX) osteoporotic rat model has been monitored using i...
In the past, bone loss in the ovariectomized (OVX) osteoporotic rat model has been monitored using i...
<p>(A–C) pQCT analyses of femurs from wild-type (wt) and tg2 mice at 10 weeks of age. A, pQCT images...